Tarsus Pharmaceuticals (TARS) Short-term Investments (2019 - 2026)

Tarsus Pharmaceuticals' Short-term Investments history runs 7 years deep, the most recent figure standing at $560000.0 for Q4 2025.

• In Q4 2025, Short-term Investments fell 99.72% year-over-year to $560000.0; the TTM figure through Dec 2025 stood at $560000.0 (down 99.72% YoY), while the FY2025 annual figure was $560000.0, down 99.72% from the prior year.
• Short-term Investments for Q4 2025 stood at $560000.0, down from $289.1 million in the prior quarter.
• The five-year high for Short-term Investments was $289.1 million in Q3 2025, with the low at $20000.0 in Q1 2021.
• The 5-year median for Short-term Investments is $104.8 million (2024), against an average of $107.3 million.
• The sharpest annual moves came in 2023 and 2025: Short-term Investments surged 46368.04% in 2023, then sank 99.72% in 2025.
• Tarsus Pharmaceuticals' Short-term Investments stood at $483000.0 in 2021, then jumped by 29996.48% to $145.4 million in 2022, then slumped by 98.28% to $2.5 million in 2023, then soared by 7778.04% to $196.6 million in 2024, then tumbled by 99.72% to $560000.0 in 2025.
• Business Quant data shows TARS's Short-term Investments at $560000.0 in Q4 2025, $289.1 million in Q3 2025, and $284.5 million in Q2 2025.